⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CORT News
Corcept Therapeutics Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
accessnewswire.com
CORT
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
globenewswire.com
CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
globenewswire.com
CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
accessnewswire.com
CORT
Fraud Investigation: Levi & Korsinsky Investigates Corcept Therapeutics Incorporated (CORT) on Behalf of Shareholders Ready to Announce with Confidence?
newsfilecorp.com
CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
accessnewswire.com
CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
accessnewswire.com
CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
accessnewswire.com
CORT
Raggiunto l'endpoint primario della sopravvivenza globale nel trial pivotale di fase 3 ROSELLA con Relacorilant in pazienti con carcinoma ovarico resistente al platino di Corcept
businesswire.com
CORT
Primair eindpunt van algehele overleving voldaan in Corcepts cruciale Fase 3-studie ROSELLA van relacorilant bij patiënten met platina-resistente eierstokkanker
businesswire.com
CORT